Skip to content

Verification study of the effect of a single intake of the test food on dry eyes and eyestrain

Verification study of the effect of a single intake of the test food on dry eyes and eyestrain - Verification study of the effect of a single intake of the test food on dry eyes and eyestrain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000041665
Enrollment
12
Registered
2021-09-12
Start date
2020-09-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Ingest 100ml high concentration test beverage at room temperature Ingest 100ml low concentration test beverage at room temperature Ingest 100ml placebo beverage at room temperature

Sponsors

IMEQRD Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. 20 to 49 years old (at the time of submission of an informed consent document). 2. Japanese male and female. 3. Those who have subjective symptoms of being dry in the condition of their eyes. 4. Those who have subjective symptoms of being tired in the condition of the eyes. 5. Those who can read QR codes using a smart phone. 6. Those who have been briefed on the clinical trial and whose written consent has been obtained.

Exclusion criteria

Exclusion criteria: 1. Those who are currently receiving some types of drug (except for the drugs that are taken as needed). Cholinergic agonists and anticholinergic drugs are not allowed even for abortive use (e.g., for use in stomach medicine and treatment of hyperhidrosis). 2. Those who have some kind of eye treatment (including dry eye). 3. Those who have had eye surgery within one year of the screening test and those who are planning to have eye surgery (including LASIK surgery) during the study period 4. People with serious or progressive diseases or symptoms (such as those for which drugs are used regularly on a daily basis) 5. Those who take health foods (foods or supplements that affect the body's composition, or are intended to maintain or restore health). 6. Those who have a past and current medical history of drug or food allergy. 7. Those who are participating in or currently participating in another clinical trial within one month prior to obtaining consent. 8. Pregnant, wishing to become pregnant between the screening date and the end of the food study, and breastfeeding 9. Those who regularly take foods containing lactobacillus and who have ingested dairy products (yogurt, kefir, sour cream, cheese, fermented butter, lactic acid bacteria drinks) containing lactobacillus even once within the past 7 days. 10. Those who plan to take dairy products containing lactobacillus (yogurt, kefir, sour cream, cheese, fermented butter, lactic acid bacteria drink) from the screening date to the end of the test period. 11. People with hay fever 12. Those who the investigator has determined to be inappropriate for this study.

Design outcomes

Primary

MeasureTime frame
Tear strage Near point distance measurement

Secondary

MeasureTime frame
Tear layer destruction time Questionnaire about eye symptoms amount of saliva

Countries

Japan

Contacts

Public ContactHirokuni Kayama

IMEQRD Co., Ltd. Planning and Sales Department

clinical-trial@imeqrd.co.jp03-6704-5968

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026